I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Christian M. Tegeler
~ 0
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Long-term efficacy of the peptide-based COVID-19 T cell act..:
Claudia Tandler
;
Jonas S. Heitmann
;
Tanja M. Michel
...
http://www.sciencedirect.com/science/article/pii/S1201971223007701. , 2024
Link:
https://doi.org/10.1016/..
?
2
1366 B7-H3xCD3 bispecific antibody as novel treatment optio..:
Ilona Hagelstein
;
Gundram Jung
;
Helmut R Salih
...
https://doaj.org/toc/2051-1426. , 2023
Link:
https://doi.org/10.1136/..
?
3
Phase I/II trial of a peptide-based COVID-19 T-cell activat..:
Jonas S. Heitmann
;
Claudia Tandler
;
Maddalena Marconato
...
https://doi.org/10.1038/s41467-023-40758-0. , 2023
Link:
https://doi.org/10.1038/..
?
4
Phase I/II trial of a peptide-based COVID-19 T-cell activat..:
Heitmann, Jonas S
;
Tandler, Claudia
;
Marconato, Maddalena
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439231/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
5
Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 F..:
Polina Kaidun
;
Samuel J. Holzmayer
;
Sarah M. Greiner
...
https://www.mdpi.com/1422-0067/24/17/13156. , 2023
Link:
https://doi.org/10.3390/..
?
6
Elevated SARS-CoV-2-Specific Antibody Levels in Patients wi..:
Christopher Hackenbruch
;
Yacine Maringer
;
Christian M. Tegeler
...
https://www.mdpi.com/1999-4915/15/3/701. , 2023
Link:
https://doi.org/10.3390/..
?
7
Elevated SARS-CoV-2-Specific Antibody Levels in Patients wi..:
Christopher Hackenbruch
;
Yacine Maringer
;
Christian M. Tegeler
...
SARS-CoV-2 and COVID-19. , 2023
Link:
https://doi.org/10.3390/..
?
8
Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 F..:
Polina Kaidun
;
Samuel J. Holzmayer
;
Sarah M. Greiner
...
Molecular Oncology. , 2023
Link:
https://doi.org/10.3390/..
?
9
HLA-DR Presentation of the Tumor Antigen MSLN Associates wi..:
Christian M. Tegeler
;
Jonas Scheid
;
Hans-Georg Rammensee
...
Cancer Immunology and Immunotherapy. , 2022
Link:
https://doi.org/10.3390/..
?
10
HLA-DR Presentation of the Tumor Antigen MSLN Associates wi..:
Christian M. Tegeler
;
Jonas Scheid
;
Hans-Georg Rammensee
...
https://www.mdpi.com/2072-6694/14/9/2260. , 2022
Link:
https://doi.org/10.3390/..
1-10
